Camlin Fine Sciences Ltd | Industry : (Chemicals) | |
---|---|---|
BSE Code : 532834 |
NSE Symbol : CAMLINFINE |
P/E(TTM) : - |
ISIN Demat : INE052I01032 |
Div & Yield% : - |
EPS(TTM) : - |
Book Value(₹) : 37.60 |
Market Cap(₹Cr) : 2,094.53 |
Face Value(₹) : 1.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 226.91 | 181.91 | 220.33 | 185.61 | 206.21 | 161.11 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 226.91 | 181.91 | 220.33 | 185.61 | 206.21 | 161.11 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 3.08 | 1.78 | 5.55 | 2.13 | 5.63 | 6.01 |
Total Income | 229.99 | 183.69 | 225.88 | 187.73 | 211.85 | 167.12 |
Total Expenditure | 309.17 | 174.98 | 247.91 | 179.72 | 184.86 | 136.02 |
PBIDT | -79.18 | 8.71 | -22.02 | 8.01 | 26.99 | 31.11 |
Interest | 17.92 | 13.62 | 13.88 | 13.30 | 15.10 | 12.05 |
PBDT | -97.10 | -4.90 | -35.90 | -5.29 | 11.89 | 19.06 |
Depreciation | 13.44 | 12.69 | 12.78 | 12.40 | 12.41 | 11.80 |
Tax | 5.44 | -3.78 | -0.63 | -1.33 | 0.20 | 1.76 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -43.36 | -0.13 | -3.98 | -4.72 | 0.74 | -0.28 |
Reported Profit After Tax | -72.62 | -13.68 | -44.07 | -11.64 | -1.46 | 5.78 |
Extra-ordinary Items | -91.53 | 0.00 | -1.93 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 18.91 | -13.68 | -42.14 | -11.64 | -1.46 | 5.78 |
EPS (Unit Curr.) | -4.34 | -0.82 | -2.65 | -0.70 | -0.09 | 0.36 |
EPS (Adj) (Unit Curr.) | -4.34 | -0.82 | -2.65 | -0.70 | -0.09 | 0.36 |
Calculated EPS (Unit Curr.) | -4.34 | -0.82 | -2.63 | -0.70 | -0.09 | 0.35 |
Calculated EPS (Adj) (Unit Curr.) | -4.34 | -0.82 | -2.63 | -0.70 | -0.09 | 0.35 |
Calculated EPS (Ann.) (Unit Curr.) | -17.34 | -3.27 | -10.53 | -2.78 | -0.35 | 1.38 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | -17.34 | -3.27 | -10.53 | -2.78 | -0.35 | 1.38 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 16.75 | 16.75 | 16.75 | 16.75 | 16.75 | 16.74 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | -34.89 | 4.79 | -9.99 | 4.32 | 13.09 | 19.31 |
PBDTM(%) | -42.79 | -2.69 | -16.29 | -2.85 | 5.77 | 11.83 |
PATM(%) | -32.00 | -7.52 | -20.00 | -6.27 | -0.71 | 3.59 |